45 Hopefully, the publication of this article will make our study objectives and methods more transparent and consequently improve the eventual utility of our study.
Early clinical trials are no exception, with efforts to improve the eventual success rate of late stage trials through evolving phase I trial methodologies, the addition of extensive pharmacodynamic studies, and early adoption of patient selection strategies.
That would be warm enough for the buckyball superconductors to work while cooled by liquid nitrogen instead of much more expensive liquid helium, greatly improving the prospects of eventual practical applications.
The introduction of the multidisciplinary team approach to the management of all patients with colorectal cancer has been instrumental in improving the decision making and eventual outcome of these patients (Kelly et al, 2003).
Cochlear implant sound processing strategies that use time-varying pulse rates to transmit fine structure information are one proposed method for improving the spectral representation of a sound with the eventual goal of improving speech recognition in noisy conditions, speech recognition in tonal languages, and music identification and appreciation.
Sept. 21, 2017 12:05 p.m. Two new Princeton-led studies provide a detailed look at an essential part of algae's growth machinery, with the eventual goal of applying this knowledge to improving the growth of crops.
Such a run could have major consequences for the eventual G.O.P. nominee by drawing Republican votes away and improving the odds for President Obama's re-election.
It is hoped that this process will improve the 'healthiness' of eventual policies.
To investigate the inter-observer agreement and, at the same time, improve the precision of the eventual exposure estimates, one 15-minute portion of each half-shift recording was analyzed by all four observers; the overlap block always occurred during the first 15-minute portion of the second block of video and resulted in 3 of the observers rating an additional 15-minute block.
The first clinical trials in relapsing-remitting MS (RRMS) using the anti-CD20 antibody rituximab were initiated based on the hypothesis that the elimination of B-cells would indirectly improve the disease course by the eventual reduction of auto-antibody formation.
